Status:

TERMINATED

Fish OIL Optimal dosE Determination Study

Lead Sponsor:

University Hospital Carl Gustav Carus

Collaborating Sponsors:

University of Giessen

Clinical Evaluation Research Unit at Kingston General Hospital

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of this trial is to determine the safety and efficacy of IV fish oil doses of 0.20 g/kg and 0.50 g/kg, compared to a control group, in critically ill patients with severe sepsis ...

Detailed Description

Objectives: The overall objective is to determine the effect of IV fish oil on 28-day mortality of critically ill patients with severe sepsis. However, prior to such a large trial, we need to determin...

Eligibility Criteria

Inclusion

  • Adult ICU patients
  • Requiring invasive or non-invasive ventilation
  • Clinical evidence of sepsis
  • Presence of one or more organ failures

Exclusion

  • \>24 hours from admission to ICU to time of consent
  • Low level of inflammatory cytokine (IL-6(qualitative assay \<100 pg/ml)
  • lack of commitment to full aggressive care (anticipated withholding or withdrawing treatments in the first week)
  • Immunocompromised (post-organ transplantation, HIV, neutropenic \[\<1000 PMN\], steroids \>20 mgs/day for 6 months).
  • Chronic non-invasive ventilation (except if they become mechanically ventilated)
  • Platelet count of \< 30 GPt/L
  • Pregnant patients. Urine/blood tests for pregnancy will be done on all women of childbearing age by each site as part of standard of ICU practice.
  • Previous enrollment in this study
  • Enrollment in other ICU intervention study
  • Allergy to fish or fish oil (shellfish allergy not an exclusion criterion)
  • Has already received enteral or IV omega-3 fatty acids during this hospitalization and current ICU admission.

Key Trial Info

Start Date :

October 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2017

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT01146821

Start Date

October 1 2013

End Date

April 1 2017

Last Update

April 19 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital Dresden

Dresden, Germany, D-01307

2

University Hospital Giessen and Marburg

Giessen, Germany, D-35392